How many volunteers were present at the Congress? : |
The 9th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2016) was a record success, attracting more than 2,600 participants from 90 different countries. |
Delegates from which countries presented in the congress? : |
COMMITTEES
Tadej Battelino, Slovenia
PROGRAM ADVISORS
Stephanie Amiel, UK
Hans de Vries, the Netherlands
Satish Garg, USA
Lutz Heinemann, Germany
Irl Hirsch, USA
Roman Hovorka, UK
Neal Kaufman, USA
Eric Renard, France
Jay Skyler, USA |
Were the delegates of any other organizations present in the congress? : |
No |
If yes, please write the names of the organizations in the box : |
|
What were the responses to your talking points? Were specific questions or concerns raised? : |
They asked questions about type of educational program that assessment in this study.
Did not need to talk with the members of the 9 th International Conference on Advanced Technologies Treatments for Diabetes (ATTD). ATTD 2015 was the global meeting place for researchers and clinicians from the fields of diabetes.There was not any specific problem to speak with the members of International Conference on Advanced Technologies Treatments for Diabetes (ATTD). |
If you met staff members, please list their full names & positions. : |
I did not meet staff members
There is not any specific problem to speak with the members of the congress |
Please inform us if there are any follow up actions we need to talk with the members of the congress : |
Did not need to talk with the members of the 9 th International Conference on Advanced Technologies Treatments for Diabetes (ATTD). ATTD 2016 was the global meeting place for researchers and clinicians from the fields of diabetes.There was not any specific problem to speak with the members of International Conference on Advanced Technologies Treatments for Diabetes (ATTD). |
Your experiences about the travel processes(Providing ticket, accommodation,...) : |
Invitation letter requests are processed immediately following the completion of my registration and has registered to the Congress and the registration fee has been paid in full .they sent me invitation letter via email. I receive Visa . I provide all the mandatory information before my request will be processed. |
Please give a briefing of your own observations and outcomes of the congress: : |
The 9th International Conference on Advanced Technologies & Treatments for Diabetes
Place: Milan, Italy
Time: February 3-6, 2016
9th International Conference on Advanced Technologies & Treatments for Diabetes
Took place in Milan, Italy more than 2,600 participants from 90 different countries. ATTD 2016 was the global meeting place for researchers and clinicians from the fields of diabetes. This innovative conference includes presentations and delivery systems, insulin pumps, glucose sensors, closed-loop systems devices for diabetic prevention, artificial pancreas, and new technologies for treating obesity and many more.
An international audience of researchers and clinicians from the fields of diabetes, endocrinology and metabolism, diabetes technology developers as well as general &family medicine practitioners are attending and presentations will be given by renowned professionals.
My abstract with title of “EFFECT OF EDUCATIONAL INTERVENTION ON NUTRITIONAL BEHAVIOR AMONG PATIENTS WITH TYPE 2 DIABETES “accept as e-poster.
Electronic poster is similar to traditional paper poster, but displayed one-site on a large LCD television screen. Electronic posters of International Conference on Advanced Technologies Treatments for Diabetes will be available at the E-poster stations in Exhibition Area on the ATTD 2016 website during the Conference and in an online archive for one year following the Conference.
Discussion sessions took place at the E-poster stations during the morning coffee break. I presented poster to discuss with organizing Committee at that time.
9th International Conference on Advanced Technologies & Treatments for finished on February 6, 2016. Good experience was obtained in this Conference and New Knowledge Attitudes Acquired about type 2 diabetes. |